Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30080988HIVENSG00000000971.17protein_codingCFHNoNo3075A0A0D9SG88
P08603
TVIS30087415HIVENSG00000000971.17protein_codingCFHNoNo3075A0A0D9SG88
P08603
TVIS30026153HIVENSG00000000971.17protein_codingCFHNoNo3075A0A0D9SG88
P08603
TVIS30026154HIVENSG00000000971.17protein_codingCFHNoNo3075A0A0D9SG88
P08603
TVIS20017373HPVENSG00000000971.17protein_codingCFHNoNo3075A0A0D9SG88
P08603
TVIS20040064HPVENSG00000000971.17protein_codingCFHNoNo3075A0A0D9SG88
P08603
TVIS20048343HPVENSG00000000971.17protein_codingCFHNoNo3075A0A0D9SG88
P08603
TVIS20047152HPVENSG00000000971.17protein_codingCFHNoNo3075A0A0D9SG88
P08603
TVIS44028275HTLV-1ENSG00000000971.17protein_codingCFHNoNo3075A0A0D9SG88
P08603
TCGA Plot Options
Drug Information
GeneCFH
DrugBank IDDB01593
Drug NameZinc
Target IDBE0009053
UniProt IDP08603
Regulation Type
PubMed IDs21396937
CitationsNan R, Farabella I, Schumacher FF, Miller A, Gor J, Martin AC, Jones DT, Lengyel I, Perkins SJ: Zinc binding to the Tyr402 and His402 allotypes of complement factor H: possible implications for age-related macular degeneration. J Mol Biol. 2011 May 13;408(4):714-35. doi: 10.1016/j.jmb.2011.03.006. Epub 2011 Mar 17.
GroupsApproved; Investigational
Direct ClassificationHomogeneous transition metal compounds
SMILES[Zn]
PathwaysDihydropyrimidinase Deficiency; Rofecoxib Action Pathway; Losartan Action Pathway; AICA-Ribosiduria; Canavan Disease; Quinapril Action Pathway; Alkaptonuria; Eprosartan Action Pathway; gamma-Glutamyltransferase Deficiency; Pterine Biosynthesis; Sulindac Action Pathway; Rescinnamine Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); beta-Ureidopropionase Deficiency; Vitamin B6 Metabolism; Retinol Metabolism; Valsartan Action Pathway; Valdecoxib Action Pathway; Irbesartan Action Pathway; Adenosine Deaminase Deficiency; Hawkinsinuria; Methionine Metabolism; Ramipril Action Pathway; Benazepril Action Pathway; beta-Alanine Metabolism; Aspartate Metabolism; Diclofenac Action Pathway; Galactosemia
PharmGKBPA451956
ChEMBLCHEMBL1201279